1. Home
  2. ICMB vs NRSN Comparison

ICMB vs NRSN Comparison

Compare ICMB & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investcorp Credit Management BDC Inc.

ICMB

Investcorp Credit Management BDC Inc.

HOLD

Current Price

$0.87

Market Cap

17.2M

Sector

Finance

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$6.90

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICMB
NRSN
Founded
2012
2017
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2M
14.2M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
ICMB
NRSN
Price
$0.87
$6.90
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
29.8K
515.9K
Earning Date
05-13-2026
03-31-2026
Dividend Yield
21.74%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.43
N/A
Revenue Next Year
N/A
$583.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.25
52 Week High
$3.12
$1.30

Technical Indicators

Market Signals
Indicator
ICMB
NRSN
Relative Strength Index (RSI) 53.80 96.50
Support Level $0.86 $0.66
Resistance Level $0.89 N/A
Average True Range (ATR) 0.03 0.06
MACD 0.01 0.41
Stochastic Oscillator 65.79 100.00

Price Performance

Historical Comparison
ICMB
NRSN

About ICMB Investcorp Credit Management BDC Inc.

Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). The investment objective of the company is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: